For colorectal cancer, higher circulating adiponectin concentrations have been associated with lower risk within the EPIC, Women's Health Initiative (WHI) and Health Professional Follow‐up (HPFS) studies, with these associations usually attenuated after BMI adjustment.7, 9, 10. Here, ADIPOQ is linked to colorectal cancer.